Steven Petrou
Co-Founder and President of Research & DevelopmentDr. Steven Petrou, BSc (Hons), PhD., also known as Steve, is the Co-founder of Praxis Precision Medicines, Inc. and is President of Research & Development from January 8, 2026 and served as its Chief Scientific Officer since January 2018 until January 8, 2026. He was Director of The Florey Institute of Neuroscience and Mental Health and Head of The Department of The Florey Institute at The University of Melbourne In Australia. He is Head of Ion Channels and Human Disease Laboratory. He served as Vice President, CNS Research of Bionomics Ltd. since January 2003. In addition to this role. Dr. Petrou is a Senior Research Fellow at the Howard Florey Institute for Experimental Physiology in Melbourne, he has extensive experience in leading a team focused on channelopathies (the study of human diseases that involve ion channel dysfunction), including the study of the molecular and physiological basis of inherited epilepsies, Dr. Petrou was responsible for the development of the world's first animal model of inherited epilepsy. Dr. Petrou received a B.S. in zoology and genetics and a Ph.D. in zoophysiology from the University of Melbourne.
Positions
- Company NamePraxis Precision Medicines, Inc.Stock CodePRAXPositionCo-Founder and President of Research & DevelopmentColleagues
- MSMarcio Silva De'SouzaPresident, CEO & Director
- DJDean Jonathan MitchellIndependent Chairman of the Board
- TETimothy Edwin KellyCFO & Treasurer
- ANAlex NemiroffGeneral Counsel & Secretary
- MTMegan T. SniecinskiChief Operating Officer
- WDWilliam Douglas YoungIndependent Director
- GNGregory NordenIndependent Director
- JAJeffrey Allan ChodakewitzIndependent Director
